Edwards Lifesciences: Strong R&D, Strategic Leadership, and Growth Amid Market Risks
Edwards Lifesciences boosts R&D and pipeline diversification under new C‑Sci Officer, driving $3.1B revenue growth and positioning future aortic‑valve & hybrid device wins amid regulatory & competitive pressures.
4 minutes to read




